Ionizable Cationic Lipids
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/US2013/034602, filed Mar 29, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,546,128 | Ionizable Cationic Lipids In force · High confidence | Translate Bio, Inc. | In force | High confidence | ||
| US 10,065,919 | Ionizable Cationic Lipids In force · High confidence | Translate Bio, Inc. | In force | High confidence | ||
| US 10,766,852 | Ionizable Cationic Lipids In force · High confidence | Translate Bio, Inc. | In force | High confidence | ||
| US 12,331,005 | Ionizable Cationic Lipids In force · Medium confidence | Translate Bio, Inc. | In force | Medium confidence | ||
| US 12,459,885 | Ionizable Cationic Lipids In force · Medium confidence | Translate Bio, Inc. | In force | Medium confidence | ||
| US 11,999,675 | Ionizable Cationic Lipids In force · Medium confidence | Translate Bio, Inc. | In force | Medium confidence | ||
| Application 18/646,567 | Ionizable Cationic Lipids Abandoned Abandoned Aug 9, 2024 | Translate Bio, Inc. | Abandoned | Abandoned Aug 9, 2024 | ||
| Application 19/351,909 | Ionizable Cationic Lipids Pending Not granted | Translate Bio, Inc. | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Translate Bio, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.